The DOI matches its Crossref record; 32 of the 37 references it cites were found in a registry or an index.
Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections
Open accessPublished version of a preprint
Abstract
Vaccination has proven effective against infection with SARS-CoV-2, as well as death and hospitalisation following COVID-19 illness. However, little is known about the effect of vaccination on other acute and post-acute outcomes of COVID-19. Data were obtained from the TriNetX electronic health records network (over 81 million patients mostly in the USA). Using a retrospective cohort study and time-to-event analysis, we compared the incidences of COVID-19 outcomes between individuals who received a COVID-19 vaccine (approved for use in the USA) at least 2 weeks before SARS-CoV-2 infection and propensity score-matched individuals unvaccinated for COVID-19 but who had received an influenza vaccine. Outcomes were ICD-10 codes representing documented COVID-19 sequelae in the 6 months after a confirmed SARS-CoV-2 infection (recorded between January 1 and August 31, 2021, i.e. before the emergence of the Omicron variant). Associations with the number of vaccine doses (1 vs. 2) and age (<60 vs. ≥ 60 years-old) were assessed. Among 10,024 vaccinated individuals with SARS-CoV-2 infection, 9479 were matched to unvaccinated controls. Receiving at least one COVID-19 vaccine dose was associated with a significantly lower risk of respiratory failure, ICU admission, intubation/ventilation, hypoxaemia, oxygen requirement, hypercoagulopathy/venous thromboembolism, seizures, psychotic disorder, and hair loss (each as composite endpoints with death to account for competing risks; HR 0.70-0.83, Bonferroni-corrected p < 0.05), but not other outcomes, including long-COVID features, renal disease, mood, anxiety, and sleep disorders. Receiving 2 vaccine doses was associated with lower risks for most outcomes. Associations between prior vaccination and outcomes of SARS-CoV-2 infection were marked in those <60 years-old, whereas no robust associations were observed in those ≥60 years-old. In summary, COVID-19 vaccination is associated with lower risk of several, but not all, COVID-19 sequelae in those with breakthrough SARS-CoV-2 infection. The findings may inform service planning, contribute to forecasting public health impacts of vaccination programmes, and highlight the need to identify additional interventions for COVID-19 sequelae.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592 · cited 1×
“23 However, our results highlight that some post-acute outcomes of SARS-CoV-2 (and notably long-COVID presentations) are likely to persist even after successful vaccination of the population, so long as breakthrough infections occur.”
Austin, P. C. (2011) · Multivariate Behavioral Research · doi:10.1080/00273171.2011.568786 · Cited by 12,242
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
Taquet, M., Geddes, J. R., Husain, M., Luciano, S., & Harrison, P. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00084-5 · Cited by 2,189 · cited 2×
“The study used TriNetX Analytics, a federated network of linked EHRs recording anonymized data from 59 healthcare organizations (HCOs), primarily in the USA, totalling 81 million patients.”
Self-citationHaas, E. J., Angulo, F. J., McLaughlin, J. M., Anis, E., Singer, S. R., Khan, F., Brooks, N., Smaja, M., Mircus, G., Pan, K., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00947-8 · Cited by 1,564 · cited 1×
“Discussion 304 It is established that vaccination protects against hospitalisation, ICU admission, and death 305 from COVID-19 (Agrawal et al., 2021; Antonelli et al., 2021; Bahl et al., 2021; Butt et al., 306 2021; Cabezas et al., 2021; Glatman-Freedman et al., 2021; Haas et al., 2021; Hyams et al., 307 2021; Mateo-U…”
Royston, P. J., & Parmar, M. (2002) · Statistics in Medicine · doi:10.1002/sim.1203 · Cited by 1,537
High-dimensional characterization of post-acute sequelae of COVID-19
Al-Aly, Z., Xie, Y., & Bowe, B. (2021) · Nature · doi:10.1038/s41586-021-03553-9 · Cited by 1,518 · cited 1×
“We investigated the 6-month incidence of all acute and post-acute outcomes which have been shown to be significantly associated with COVID-19 in four large-scale studies based on electronic health records (Al-Aly et al., 2021; Daugherty et al., 2021; Taquet et al., 2021b, 2021a), namely:”
Taquet, M., Luciano, S., Geddes, J. R., & Harrison, P. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30462-4 · Cited by 1,484
Self-citationTaquet, M., Dercon, Q., Luciano, S., Geddes, J. R., Husain, M., & Harrison, P. J. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003773 · Cited by 948
Self-citationAntonelli, M., Penfold, R. S., Merino, J., Sudre, C. H., Molteni, E., Berry, S., Canas, L. S., Graham, M. S., Klaser, K., Modat, M., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00460-6 · Cited by 843
Haukoos, J. S., & Lewis, R. (2015) · JAMA · doi:10.1001/jama.2015.13480 · Cited by 842
Vaccine Breakthrough Infections with SARS-CoV-2 Variants
Hacisuleyman, E., Hale, C., Saito, Y., Blachere, N. E., Bergh, M., Conlon, E. G., Schaefer-Babajew, D. J., DaSilva, J., Muecksch, F., Gaebler, C., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2105000 · Cited by 716
B-cell responses to vaccination at the extremes of age
Siegrist, C.-A., & Aspinall, R. (2009) · Nature Reviews Immunology · doi:10.1038/nri2508 · Cited by 659
de Lusignan, S., Dorward, J., Correa, A., Jones, N. R., Akinyemi, O., Amirthalingam, G., Andrews, N., Byford, R. C., Dabrera, G., Elliot, A. J., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30371-6 · Cited by 594
Using electronic health records for population health research: a review of methods and applications
Casey, J. A., Schwartz, B. S., Stewart, W. F., & Adler, N. E. (2016) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-032315-021353 · Cited by 590
Antonelli, M., Penfold, R., Merino, J., Sudre, C. H., Molteni, E., Berry, S., Canas, L., Graham, M. S., Kläser, K., Marc Modat, A., et al. (2022) · UCL Discovery (University College London) · Cited by 512
Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study
Daugherty, S. E., Guo, Y., Heath, K., Dasmariñas, M. C., Jubilo, K. G., Samranvedhya, J., Lipsitch, M., & Cohen, K. (2021) · BMJ · doi:10.1136/bmj.n1098 · Cited by 437
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine
Wu, K., Werner, A. P., Koch, M., Choi, A., Narayanan, E., Stewart-Jones, G. B. E., Colpitts, T., Bennett, H., Boyoglu-Barnum, S., Shi, W., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2102179 · Cited by 409
Latkin, C. A., Dayton, L., Yi, G. T., Colon, B., & Kong, X. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246970 · Cited by 252
Agrawal, U., Katikireddi, S. V., McCowan, C., Mulholland, R. H., Azcoaga-Lorenzo, A., Amele, S., Fagbamigbe, A. F., Vasileiou, E., Grange, Z., Shi, T., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00380-5 · Cited by 134
Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis
Nyberg, T., Twohig, K. A., Harris, R., Seaman, S. R., Flannagan, J., Allen, H., Charlett, A., Angelis, D. D., Dabrera, G., & Presanis, A. M. (2021) · BMJ · doi:10.1136/bmj.n1412 · Cited by 133
Hyams, C. J., Marlow, R. D., Maseko, Z., King, J., Ward, L., Fox, K., Heath, R., Tuner, A., Friedrich, Z., Morrison, L., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00330-3 · Cited by 132
Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis
Nyberg, T., Twohig, K. A., Harris, R., Seaman, S. R., Flannagan, J., Allen, H., Charlett, A., Angelis, D. D., Dabrera, G., & Presanis, A. M. (2021) · Apollo (University of Cambridge) · doi:10.17863/cam.71427 · Cited by 131
Bahl, A., Johnson, S., Maine, G. N., Garcia, M. H., Nimmagadda, S., Qu, L., & Chen, N. (2021) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2021.100065 · Cited by 115
Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination
Butt, A. A., Nafady-Hego, H., Chemaitelly, H., Abou-Samra, A.-B., Khal, A. A., Coyle, P. V., Kanaani, Z. A., Kaleeckal, A. H., Latif, A. N., Masalmani, Y. A., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.08.008 · Cited by 94
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Roest, S., Hoek, R. A. S., & Manintveld, O. C. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2104281 · Cited by 88
Cabezas, C., Coma, E., Mora, N., Li, X., Martínez, M., Avilés, F. F., Fàbregas, M., Hermosilla, E., Jover, A., Contel, J. C., et al. (2021) · BMJ · doi:10.1136/bmj.n1868 · Cited by 81
Vaccine Breakthrough Infections with SARS-CoV-2 Variants
Rana, K., Mohindra, R., & Pinnaka, L. V. M. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2107808 · Cited by 77
Manja, V., Albashir, S. M., & Guyatt, G. H. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.12.001 · Cited by 54
Glatman‐Freedman, A., Bromberg, M., Dichtiar, R., Hershkovitz, Y., & Keinan‐Boker, L. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103574 · Cited by 52
McEwen, A. E., Cohen, S., Bryson‐Cahn, C., Liu, C., Pergam, S. A., Lynch, J. B., Schippers, A., Strand, K., Whimbey, E. E., Mani, N. S., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab581 · Cited by 51
Mateo‐Urdiales, A., Alegiani, S. S., Fabiani, M., Pezzotti, P., Filia, A., Massari, M., Riccardo, F., Tallon, M., Proietti, V., Manso, M. D., et al. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.25.2100507 · Cited by 28
Flagged first, then by citations
5 of the 37 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- McEwen, 2021, Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State, Clin. Infect. Dis.
Cited by
Sorted by citations
Long COVID: major findings, mechanisms and recommendations
Davis, H. E., McCorkell, L., Vogel, J. M., & Topol, E. J. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00846-2 · Cited by 4,153
Taquet, M., Sillett, R., Zhu, L., Mendel, J., Camplisson, I., Dercon, Q., & Harrison, P. J. (2022) · The Lancet Psychiatry · doi:10.1016/s2215-0366(22)00260-7 · Cited by 737
Self-citationNotarte, K. I., Catahay, J. A., Velasco, J. V., Pastrana, A., Ver, A. T., Pangilinan, F. C., Peligro, P. J., Casimiro, M., Guerrero, J. J., Gellaco, M. M. L., et al. (2022) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101624 · Cited by 480
Altmann, D. M., Whettlock, E. M., Liu, S., Arachchillage, D. J., & Boyton, R. J. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00904-7 · Cited by 471
Effect of covid-19 vaccination on long covid: systematic review
Byambasuren, O., Stehlik, P., Clark, J. M., Alcorn, K., & Glasziou, P. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2022-000385 · Cited by 340
Metadata
- Authors
- Taquet, M., Dercon, Q., & Harrison, P. J.
- Affiliations
- Oxford Health NHS Foundation Trust (GB)
- MRC Cognition and Brain Sciences Unit (GB)
- Corresponding author
- Taquet, Maxime
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2022-07
- Volume
- 103
- Pages
- 154-162
- ISSN
- 0889-1591 (ISSN-L)
- PMC
- PMC9013695
- OpenAlex
- W4225562523
- Cited by
- 246
- References
- 37
- Citations by year
- 2026: 8 · 2025: 28 · 2024: 68 · 2023: 79 · 2022: 60
- FWCI
- 28.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain Behavior and Immunity (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- National Institute for Health and Care Research
- AXA Research Fund (G102329)
- NIHR Oxford Biomedical Research Centre (BRC-1215-20005)
- Medical Research Council (SUAG/077 G101400)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Keywords
- breakthrough infection, SARS-CoV-2, post-COVID-19 sequelae, long COVID, respiratory failure, intensive care unit admission, intubation and mechanical ventilation, hypoxemia, venous thromboembolism, hypercoagulability, seizures, psychosis, hair loss, vaccine dose number, older adults, Omicron variant
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Vaccines, Post-Acute COVID-19 Syndrome, Humans, Middle Aged, Retrospective Studies, Vaccination, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
